ClinicalTrials.gg
Status unknownNCT05247073Updated Mar 29, 2022

Mostafa Maged Four-stitch Technique in Closure the Episiotomy During Vaginal Delivery

An interventional study of patients of controlled group with routine closure of episiotomy and The Mostafa Maged four-stitch technique fore closure of the episiotomy in Vaginal Delivery, Suture, Complication and Tear; Cervix, sponsored by Fayoum University. Status unknown. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2022-03-29.

Sponsored by Fayoum University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Most primigravida is confronted with episiotomy during childbirth to prevent the perineal and vaginal lacerations which could be performed at birth. There are many types of episiotomy which are median, mediolateral, and J-shaped episiotomy.

Prevention of the formation of the dead space during the repair of episiotomy so avoiding hematoma formation in the episiotomy area after child-birth.

The Mostafa Maged four-stitch technique uses absorbable vicryl threads with round needles 75 mm.

Read the detailed description

Methodology: This technique will be applied to all women with episiotomy at the time of delivery or having tears in the perineum or the vagina. The technique uses absorbable vicryl threads with round needles 75 mm long. The technique includes the vaginal epithelium and the deep muscle layer together continuously at the same sutures. Assessment of the perineal area in the next twenty-four hours till discharge looking for (edema - hematoma - septic wound - continence - ecchymosis - dyspareunia).

02

Conditions studied

  • Vaginal Delivery
  • Suture, Complication
  • Tear; Cervix
  • Hematoma
  • Ecchymosis

Keywords

  • Primigravida,
  • Episiotomy,
  • Childbirth,
  • Mostafa Maged
  • ecchymosis
03

In context

Lacerations

174 studies on the registry are indexed under Lacerations; 43 are open to participants now.

This study's planned enrollment of 50 is below the median of 65 across 128 interventional studies indexed under Lacerations.

Browse Lacerations studies →

Lead sponsor

Fayoum University is the lead sponsor of 148 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Primigravida patients having episiotomies or tears in the vagina
  2. Age between 18 to 40 years old

Exclusion criteria

Exclusion Criteria:

  1. Smokers
  2. Diabetics
  3. Morbidly obese patients
  4. Chronic diseases such as renal diseases
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Other
    Patients of controlled group with routine closure of the episiotomy

    The vagina will be stitched using a continuous locking stitch and the perineal muscles and skin are repaired using approximately three or four individual stitches, each needing to be knotted separately to prevent them from dislodging.

    Procedure: patients of controlled group with routine closure of episiotomy

  • Active comparator
    Patients of study group with Mostafa Maged technique for closure of the episiotomy

    The vagina will be stitched with the Mostafa Maged technique, The Mostafa Maged four-stitch technique uses absorbable vicryl threads with round needles 75 mm. The technique will prevent dead space formation, Good and tight hemostasis of the episiotomy strong approximation of the two edges of the episiotomy.

    Procedure: The Mostafa Maged four-stitch technique fore closure of the episiotomy

Interventions

  • Procedurepatients of controlled group with routine closure of episiotomy

    Perineal trauma is traditionally repaired in three stages: a continuous locking stitch is inserted to close the vaginal trauma, commencing at the apex of the wound and finishing at the level of the fourchette with a loop knot. The perineal muscles are then re-approximated with three or four interrupted sutures and finally, the perineal skin is closed by inserting continuous subcutaneous or interrupted transcutaneous stitches. The skin is then closed with inverted interrupted stitches placed in the subcutaneous tissue a few millimeters under the perineal skin edges (not transcutaneously).

  • ProcedureThe Mostafa Maged four-stitch technique fore closure of the episiotomy

    Identification of the apex of the episiotomy, then a simple suture is taken (0.5 cm) behind the apex of the episiotomy. First, the needle is inserted at the vaginal mucosa of the right edge of the episiotomy then extract the needle. The second stitch is inserted on the deep muscle layer of the same side (Right side) of the episiotomy cutting edge then extracting the needle. Then, insert the needle again on the left side of the episiotomy incision in the deep muscle layer on the left side of the episiotomy incision directing the tip of the needle upwards parallel to the second stitch taken. The fourth step is inserting the needle in the vaginal mucosa of the left side parallel to the first stitch. Continue suturing the episiotomy incision continuously in the same way till reaching the remnant of the hymen. Then suture the superficial perineal muscle in a continuous manner and the skin in a subcuticular manner as well.

06

What researchers measure

Primary outcomes

  1. Heamostasis of the episiotomy

    Bleeding from the epistiomy or heamatoma at the epistomy

    Time frame: 4 weeks after delivery

  2. No edema at the site of episiotomy

    Swelling or ecchymosis and edema at the edges of episiotomy

    Time frame: 4 weeks after delivery

  3. No infection at the episiotomy

    Redness,hotness and bad odour of vaginal discharge

    Time frame: 4 weeks after delivery

Secondary outcomes

  1. Sexual dysfunction (pain during sexual intercourse)

    Pain during sexual intercourse

    Time frame: 4 weeks after delivery

  2. Anorectal dysfunction

    Inability to control passage of stool or flatus or both

    Time frame: 4 weeks after delivery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2022; primary completion for Apr 2022, 1 month later.

Of 46 non-industry interventional studies with no phase under Lacerations, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 72. This study's planned 1 month is below that.

Counting every sponsor, half of 50 studies reached it within 19 months; a quarter within 12 and three quarters within 72.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2022
First posted
Feb 18, 2022
StartEst.
Mar 2022
Primary completionEst.
Apr 2022
CompletionEst.
Apr 2022
Last update
Mar 29, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05247073
Lead sponsor
Fayoum University
Responsible party
rehab abdelhamid aboshama (lecturer of obstetrics and gynecology Faculty of medicine, Fayoum University) — Principal investigator
First posted
Feb 18, 2022
Start date
Mar 2022 (estimated)
Primary completion
Apr 2022 (estimated)
Completion
Apr 2022 (estimated)
Last update
Mar 29, 2022

Study contacts

rehab A aboshama, lecturer
Contact
ras07@fayoum.edu.eg
01156608221
Mostafa M Ali, resident
Contact
supermostafa200@yahoo.com
01093028005
Laila E Abdelfattah, Ass. prof
principal investigator · Associated professor of obestatrics and gynecology Faculty of medicine Fayoume university

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion